PHO at the 2014 Canadian Immunization Conference
One hundred years ago, infectious diseases were the leading cause of death worldwide. In Canada, they now cause less than 5% of all deaths – largely thanks to vaccines. — CIC 2014
Immunization is a critical public health issue and Public Health Ontario is determined to ensure that accurate and credible research and data about immunization and vaccine-preventable diseases (VPDs) is made available to inform the public health community, immunizers, vaccine manufacturers, and the public.
This is why Public Health Ontario (PHO) will be a significant presence at the 2014 Canadian Immunization Conference, where our staff will share our immunization research and program evaluation work via posters and sessions on surveillance of vaccine coverage, VPD burden/susceptibility and vaccine safety. This year’s event, organized by the Canadian Public Health Association (CPHA), will be held in Ottawa from December 2 to 4. The conference brings together individuals from public health, health care, academia, government, and business, all of whom are committed to making immunization a primary area of focus in health.
Immunize Canada, a coalition of national non-governmental, professional, health, consumer, government and private sector organizations indicates that immunization protects individuals and communities by preventing the spread of disease. As more people are immunized the disease risk for everyone is reduced. Immunization has probably saved more lives in Canada in the last 50 years than any other health intervention. Immunization is the single most cost-effective health investment, making it a cornerstone in the effort to promote health. Immunization is imperative to the health of individuals and the communities they live in and PHO will continue to work collaboratively with the ministry of health and long term care by sharing knowledge and expertise to facilitate evidence based public health practice.
Check out the event program and the schedule to see where we’ll be.
Immunization Coverage in Canada
| Sarah Wilson
December 2: 11:00 a.m. – 12:30 p.m. Room 210
|Celebrating the National Advisory Committee on Immunization 50th Anniversary
December 3: 9:00 – 10:30 a.m. Canada Hall 1 (Level 3)
|Challenges with current vaccines: Risk and benefits of rotavirus vaccines: balancing intussusception and effectiveness of the rotavirus vaccine
December 3: 11:00 – 12:30 p.m. Room 208
|Lessons learned and strategies for maintaining measles elimination
||December 3: 11:00 a.m. – 12:30 p.m. Room 210|
|Making recommendations on vaccines: Marrying science and best judgement
||December 3: 14:30 – 16:00 p.m. Room 208|
|Oral Abstract Session 2: Who’s at risk? The incidence of invasive pneumococcal disease in Ontario
||December 2: 11:00 – 12:30 pm Room 204|
|Oral Abstract Session 2: Randomized Evaluation of Live Attenuated vs. Trivalent Inactivated influenza Vaccines in Schools (RELATIVES) pilot study: preliminary results from the household surveillance sub-study
||December 3: 14:30 – 16:00 pm Room 204|
Co-Developed Accredited Learning Activities
|Two B’s? Or not Two B’s? Examining quadrivalent influenza vaccines
||December 3 – 12:45 ‐ 14:15 pm Room 201|